Scale-Up and Post-Approval Changes (SUPAC)

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

The FDA-recommended testing and filing actions to be taken by a pharmaceutical firm when it changes the manufacturing processes of a drug product that has already been approved via an NDA or ANDA.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters